Literature DB >> 173609

The control of insulin receptors in the New Zealand obese mouse.

D Baxter, N R Lazarus.   

Abstract

Insulin receptor concentrations in liver plasma membranes of New Zealand Obese (NZO) mice have been studied. When NZO mice were implanted with normal islets of Langerhans their blood glucose and plasma insulin declined. When the implanted islets were removed these changes were reversed and the mice reverted to their insulin resistant state. Changes were observed in the binding of 125I-insulin to liver plasma membranes of implanted NZO mice. Binding increased when the plasma insulin was decreased and conversely insulin binding decreased when the plasma insulin levels became elevated. The increased insulin binding was not accompanied by any changes in the affinity of NZO liver receptors for insulin.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 173609     DOI: 10.1007/bf00422389

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  13 in total

1.  Impairment of insulin binding to the fat cell plasma membrane in the obese hyperglycemic mouse.

Authors:  P Freychet; M H. Laudat; P Laudat; G Rosselin; C R. Kahn; P Gorden; J Roth
Journal:  FEBS Lett       Date:  1972-09-15       Impact factor: 4.124

2.  GROWTH CHARACTERISTICS, GLUCOSE TOLERANCE AND INSULIN SENSITIVITY OF NEW ZEALAND OBESE MICE.

Authors:  O B CROFFORD; C K DAVIS
Journal:  Metabolism       Date:  1965-03       Impact factor: 8.694

3.  Immunoassay of insulin with insulin antibody preciptate.

Authors:  C N HALES; P J RANDLE
Journal:  Lancet       Date:  1963-01-26       Impact factor: 79.321

4.  Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance.

Authors:  C R Kahn; D M Neville; J Roth
Journal:  J Biol Chem       Date:  1973-01-10       Impact factor: 5.157

5.  A modified method for the isolation of the plasma membrane from rat liver.

Authors:  T K Ray
Journal:  Biochim Biophys Acta       Date:  1970-01-06

6.  Return to normal of blood-glucose, plasma-insulin, and weight gain in New Zealand obese mice after implantation of islets of Langerhans.

Authors:  R J Gates; M I Hunt; R Smith; N R Lazarus
Journal:  Lancet       Date:  1972-09-16       Impact factor: 79.321

7.  Further studies on the amelioration of the characteristics of New Zealand Obese (NZO) mice following implantation of islets of Langerhans.

Authors:  R J Gates; M I Hunt; N R Lazarus
Journal:  Diabetologia       Date:  1974-10       Impact factor: 10.122

8.  Inhibition of the nucleotidase effect of alkaline phosphatase by beta-glycerophosphate.

Authors:  A Belfield; D M Goldberg
Journal:  Nature       Date:  1968-07-06       Impact factor: 49.962

9.  Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects.

Authors:  M Perley; D M Kipnis
Journal:  Diabetes       Date:  1966-12       Impact factor: 9.461

10.  Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.

Authors:  J R Gavin; J Roth; D M Neville; P de Meyts; D N Buell
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

View more
  10 in total

Review 1.  Interactions polypeptide hormones with cell membrane specific receptors: studies with insulin and glucagon.

Authors:  P Freychet
Journal:  Diabetologia       Date:  1976-05       Impact factor: 10.122

Review 2.  Studies on the mechanism of insulin action: basic concepts and clinical implications.

Authors:  K D Hepp
Journal:  Diabetologia       Date:  1977-05       Impact factor: 10.122

3.  Membrane receptors for hormones and neurotransmitters.

Authors:  C R Kahn
Journal:  J Cell Biol       Date:  1976-08       Impact factor: 10.539

4.  Isolation of material displaying insulin-like immunological biological activity from the brain of the blowfly Calliphora vomitoria.

Authors:  H Duve; A Thorpe; N R Lazarus
Journal:  Biochem J       Date:  1979-11-15       Impact factor: 3.857

5.  Insulin binding to monocytes and in vivo peripheral insulin sensitivity are normal in Graves' disease.

Authors:  P Cavallo-Perin; A Bruno; C Bozzo; L Boine; P Estivi; V Martina; G Gallone; G Pagano
Journal:  J Endocrinol Invest       Date:  1988-12       Impact factor: 4.256

6.  Resistance to hepatic action of vasopressin in genetically obese (ob/ob) mice.

Authors:  D A Hems; G Y Ma
Journal:  Biochem J       Date:  1976-10-15       Impact factor: 3.857

7.  Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding.

Authors:  R A DeFronzo; V Soman; R S Sherwin; R Hendler; P Felig
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

8.  Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting.

Authors:  R S Bar; P Gorden; J Roth; C R Kahn; P De Meyts
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

9.  Islet transplantation in genetically determined diabetes.

Authors:  C F Barker; L G Frangipane; W K Silvers
Journal:  Ann Surg       Date:  1977-10       Impact factor: 12.969

10.  Increased insulin binding by hepatic plasma membranes from diabetic rats: normalization by insulin therapy.

Authors:  M B Davidson; S A Kaplan
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.